Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer
Verena Zuber, Francesco Bettella, Aree Witoelar, Ole A. Andreassen, Ian G. Mills, Alfonso Urbanucci*, Rosalind Eeles, Doug Easton, Zsofia Kote-Jarai, Ali Amin Al Olama, Sara Benlloch, Kenneth Muir, Graham G. Giles, Fredrik Wiklund, Henrik Gronberg, Christopher A. Haiman, Johanna Schleutker, Maren Weischer, Ruth C. Travis, David NealPaul Pharoah, Kay Tee Khaw, Janet L. Stanford, William J. Blot, Stephen Thibodeau, Christiane Maier, Adam S. Kibel, Cezary Cybulski, Lisa Cannon-Albright, Hermann Brenner, Jong Park, Radka Kaneva, Jyotsna Batra, Manuel R. Teixeira, Hardev Pandha, Georgia Chenevix-Trench, Manjeet Humphreys, R. J. Hung, Y. Han, P. Brennan, H. Bickeböller, A. Rosenberger, R. S. Houlston, N. Caporaso, M. T. Landi, X. Wu, Qin Wang, Stig E. Bojesen, Sune F. Nielsen, Borge G. Nordestgaard, the PRACTICAL Consortium, the COGS-CRUK GWAS, the BCAC Consortium, the TRICL Consortium
Dyk ned i forskningsemnerne om 'Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer'. Sammen danner de et unikt fingeraftryk.